Fungal lycopene: The biotechnology of its production and prospects for its application in medicine

Feofilova, E. P.; Tereshina, V. M.; Memorskaya, A. S.; Dul’kin, L. M.; Goncharov, N. G.
November 2006
Microbiology (00262617);Nov2006, Vol. 75 Issue 6, p629
Academic Journal
This article deals with the lycopene of mycelial fungi. It pays special attention to its physical and chemical properties, occurrence in nature, biological functions, and the biotechnology of lycopene production. Data are presented concerning the medically important properties of lycopene and the drug Mycolycopene prepared on its basis. Its prospective use in the therapy of prostate cancers is discussed.


Related Articles

  • Prostate Carcinogenesis in N-methyl-N-nitrosourea (NMU)—Testosterone-Treated Rats Fed Tomato Powder, Lycopene, or Energy-Restricted Diets. Boileau, Thomas W.-M.; Zhiming Liao, Thomas W.-M.; Kim, Sunny; Lemeshow, Stanley; Erdman Jr., John W.; Clinton, Steven K. // JNCI: Journal of the National Cancer Institute;11/5/2003, Vol. 95 Issue 21, p1578 

    Background: Consumption of tomato products or lycopene and energy restriction have been hypothesized to reduce the risk of human prostate cancer. We investigated the effects of these dietary variables in a rat model of prostate carcinogenesis. Methods: Male rats (n = 194) treated with...

  • Lycopene in treatment of high-grade gliomas: A pilot study. Puri, Tarun; Goyal, Shikha; Julka, Pramod K.; Nair, Omana; Sharma, Daya N.; Rath, Goura K. // Neurology India;Jan2010, Vol. 58 Issue 1, p20 

    Background: The therapeutic benefit of lycopene is well established for carcinoma prostate in various clinical trials and has been proposed for other malignancies including high-grade gliomas. Setting and Design: Randomized placebo control study in the Department of Radiation Oncology of a...

  • Focal Laser Ablation for Localized Prostate Cancer: Principles, Clinical Trials, and Our Initial Experience. Lee, Ted; Mendhiratta, Neil; Sperling, Dan; Lepor, Herbert // Reviews in Urology;2014, Vol. 16 Issue 2, p55 

    Focal therapy of prostate cancer is an evolving treatment strategy that destroys a predefined region of the prostate gland that harbors clinically significant disease. Although long-term oncologic control has yet to be demonstrated, focal therapy is associated with a marked decrease in...

  • Proton Beam Therapy for Localized Prostate Cancer 101: Basics, Controversies, and Facts. Wisenbaugh, Eric S.; Andrews, Paul E.; Ferrigni, Robert G.; Schild, Steven E.; Keole, Sameer R.; Wong, William W.; Vora, Sujay A. // Reviews in Urology;2014, Vol. 16 Issue 2, p67 

    Proton beam therapy for prostate cancer has become a source of controversy in the urologic community, and the rapid dissemination and marketing of this technology has led to many patients inquiring about this therapy. Yet the complexity of the technology, the cost, and the conflicting messages...

  • Study Examines Long-Term Outcomes After Prostate Cancer Diagnosis. Zielinski, Sarah L. // JNCI: Journal of the National Cancer Institute;6/1/2005, Vol. 97 Issue 11, p795 

    Reports that men with low-grade prostate cancer have a low risk of dying from the disease, according to results from a long-term study. Retrospective, population-based cohort study of men diagnosed with clinically localized prostate cancer between 1971 and 1984; Observation that the data do not...

  • Oncology Brief from ASCO 2015: Update on Kidney Cancer and Prostate Cancer. Kapoor, Anil // Canadian Urological Association Journal;Jul/Aug2015 Supplement, pS157 

    The article offers information on the 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO) that discussed several papers on oncology research. Several papers discussed include systemic therapy in metastatic prostate cancer, benefits of early addition of docetaxel to hormone...

  • Improved irritative voiding symptoms 3 years after stereotactic body radiation therapy for prostate cancer. Rana, Zaker; Cyr, Robyn A.; Chen, Leonard N.; Kim, Brian S.; Moures, Rudy A.; Yung, Thomas M.; Lei, Siyuan; Collins, Brian T.; Suy, Simeng; Dritschilo, Anatoly; Collins, Sean P.; Lynch, John H. // Frontiers in Oncology;Oct2014, Vol. 4, p1 

    Background: Irritative voiding symptoms are common in elderly men and following prostate radiotherapy. There is limited clinical data on the impact of hypofractionated treatment on irritative voiding symptoms. This study sought to evaluate urgency, frequency, and nocturia following stereotactic...

  • Development of a nomogram model predicting current bone scan positivity in patients treated with androgen-deprivation therapy for prostate cancer. Gotto, GeoffreyT.; Changhong Yu; Kattan, Michael W.; Bernstein, Melanie; Eastham, James A. // Frontiers in Oncology;Oct2014, Vol. 4, p1 

    Purpose: To develop a nomogram predictive of current bone scan positivity in patients receiving androgen-deprivation therapy (ADT) for advanced prostate cancer; to augment clinical judgment and highlight patients in need of additional imaging investigations. Materials and methods: A...

  • US Oncologist Surveys and Other New Research Reports by The Assessment Group Published by MarketPublishers.com.  // Biomedical Market Newsletter;5/21/2011, p33 

    The article reports on the addition of The Assessment Group's U.S. Oncologist Surveys and other research reports to the catalogue of Market Publishers Ltd. The U.S. Oncologist Surveys include topics about the treatment for advanced prostate cancer, treatment for metastatic clear cell renal cell...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics